A mysterious inflammatory condition that mimics cancer and lupus, often baffling doctors for years.
In short: Adult-onset Still's disease is a rare, systemic inflammatory disorder that frequently presents as a diagnostic puzzle. Because its symptoms—high fevers, joint pain, and rashes—overlap with infections, malignancies, and autoimmune diseases, clinicians must rule out other conditions before confirming this elusive diagnosis, which remains a true medical challenge.
Adult-onset Still's disease (AOSD) is characterized by a classic triad of symptoms: high, spiking fevers, joint pain, and a distinctive salmon-colored rash. Patients often experience systemic inflammation that can affect the liver, spleen, and lymph nodes. Because these symptoms mirror those of lymphoma, lupus, and various infections, AOSD is considered a diagnosis of exclusion. Clinicians often rely on the Yamaguchi criteria, which requires at least five clinical features, including two major ones, to establish a diagnosis. While the exact cause remains unknown, researchers suspect it may be triggered by bacterial or viral infections.
The disease follows varied patterns, ranging from a single, self-limiting episode to chronic, debilitating cycles of inflammation. In some cases, the condition manifests as a polycyclic systemic disease, where patients endure recurrent flares that require escalating medical intervention. Standard treatment typically begins with corticosteroids like prednisone to manage acute inflammation. When these are insufficient, physicians may turn to disease-modifying antirheumatic drugs (DMARDs) or targeted biologic therapies, such as those blocking interleukin-1 (IL-1) or interleukin-6 (IL-6). In 2020, the FDA approved canakinumab, a monoclonal antibody targeting IL-1β, as a specific treatment option for the disease.
While the prognosis is generally favorable, AOSD can lead to severe, life-threatening complications. Inflammation can damage the heart—causing pericarditis or myocarditis—or lead to fluid accumulation around the lungs. A rare but critical complication is macrophage activation syndrome (MAS), where the immune system enters a dangerous state of overdrive, potentially harming multiple organs. Because of these risks, early detection and cytokine-directed therapy are essential. Ongoing research is currently investigating whether proteins like calprotectin could eventually serve as biomarkers to improve the accuracy of diagnosis and the monitoring of disease activity.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Adult Still disease - Symptoms and causes
- Also: Adult-onset Still's disease
- Also: Refractory Relapsing-Remitting Adult-Onset Still's Disease in an Adolescent Female: A Rare Case Report.
- Also: A Diagnosis of Exclusion: Unraveling Adult-Onset Still's Disease.
To cite this card, link to https://intellectplus.co.uk/app/health-adult-onset-still-s-disease.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Health, medicine and disease · More in Health · Latest · A–Z · All topics
